Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Vice President and Chief Scientific Officer at Noven Pharmaceuticals, Inc.
Dr. Lipp has more than 25 years of experience in transdermals and drug delivery including 14 years at Schering A.G., where he rose to the position of Head of Pharmaceutical Development. He also served as the Vice President Pharmaceutical Sciences R&D at Eli Lilly where he was responsible for successfully managing a portfolio of new chemical and biological entities plus life cycle management projects in all phases of clinical development. Dr. Lipp joins Noven from Lipp Life Sciences LLC, a firm he founded in 2012, which focused on advising clients in the areas of innovation strategy, innovation process, technology assessment, R&D portfolio review, and marketed products. Dr. Lipp has also been serving as a Founding Advisory Board Member for the Catalent Applied Drug Delivery Institute.
Dr. Lipp has more than 130 publications in the area of pharmaceutical science and drug delivery, including over 20 patents covering five marketed medicines. He earned his Ph.D. in Medicinal Chemistry from Freie Universität Berlin in Berlin, Germany.